ExpreS2ion Biotech Holding AB
STO:EXPRS2
During the last 3 months ExpreS2ion Biotech Holding AB insiders have not bought any shares, and have not sold any shares. The stock price has dropped by 67% over this period ( loading = false, 5000)" href="https://new.alphaspread.com/comparison/sto/exprs2/vs/indx/omxs30">open performance analysis).
The last transaction was made on Nov 17, 2021 by Bent Frandsen , who bought 49.3k SEK worth of EXPRS2 shares.
During the last 3 months ExpreS2ion Biotech Holding AB insiders have not bought any shares, and have not sold any shares. The stock price has dropped by 67% over this period ( loading = false, 5000)" href="https://new.alphaspread.com/comparison/sto/exprs2/vs/indx/omxs30">open performance analysis).
The last transaction was made on Nov 17, 2021 by Bent Frandsen , who bought 49.3k SEK worth of EXPRS2 shares.
ExpreS2ion Biotech Holding AB
Glance View
Expres2ion Biotech Holding AB engages in the development of a portfolio of vaccines for diseases such as COVID-19, influenza, and breast cancer. The company is headquartered in Helsingborg, Skane and currently employs 29 full-time employees. The company went IPO on 2016-07-29. The firm specializes in developing cell lines and processes based on a non-viral Drosophila S2 cells expression system. The firm's ExpreS2 recombinant protein expression platform supports all phases of drug discovery, research and development and manufacturing. ExpreS2 is a non-viral insect cell expression system that establishes stable polyclonal pools that provide high-protein expression levels without selection pressure. The system is designed for transient or stable transfections using vector deoxyribonucleic acid containing a hybrid promoter. The company also ensures high cell density without aggregation or toxic metabolite build-up issues. Through the joint venture AdaptVac ApS, the Company applies a Plug-and-Play Virus Like Particle technology for development of therapeutic and prophylactic vaccines within oncology, infectious diseases and immunological disorders.
What is Insider Trading?
Insider trading refers to the buying or selling of a company’s stock by individuals with access to non-public, material information about the company.
While legal insider trading occurs when insiders follow disclosure rules, illegal insider trading involves trading based on confidential information and is prohibited by law.
Why is Insider Trading Important?
It isn't a coincidence that corporate executives seem to always buy at the right times. After all, they have access to every bit of company information you could ever want.
However, the fact that company executives have unique insights doesn't mean that individual investors are always left in the dark. Insider trading data is out there for all who want to use it.
Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.